New ALS Drug Slips Through Telling “Phase II” Clinical Trials

A drug already used to treat symptoms of epilepsy has potential to slow the muscle weakening that comes with amyotrophic lateral sclerosis (ALS), scientists report after completing a Phase II clinical trial-an early, small-scale test to show if the drug works and continues to be safe...
This entry was posted in News from Other Sources. Bookmark the permalink. Both comments and trackbacks are currently closed.